These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36456195)

  • 1. Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
    Davis SE; Ferris MJ; Ananthan S; Augelli-Szafran CE; Zhu J
    J Pharmacol Exp Ther; 2023 Feb; 384(2):306-314. PubMed ID: 36456195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.
    Zhu J; Quizon PM; Wang Y; Adeniran CA; Strauss MJ; Jiménez-Torres AC; Patel P; Cirino TJ; Eans SO; Hammond HR; Deliscar LS; O'Hara P; Saini SK; Ofori E; Vekariya RH; Zhang S; Moukha-Chafiq O; Nguyen TH; Ananthan S; Augelli-Szafran CE; Zhan CG; McLaughlin JP
    Neuropharmacology; 2022 Dec; 220():109239. PubMed ID: 36126727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Strauss M; O'Donovan B; Ma Y; Xiao Z; Lin S; Bardo MT; Ortinski PI; McLaughlin JP; Zhu J
    J Pharmacol Exp Ther; 2020 Aug; 374(2):241-251. PubMed ID: 32461322
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Jimenez-Torres AC; Hastie JA; Davis SE; Porter KD; Lei B; Moukha-Chafiq O; Zhang S; Nguyen TH; Ananthan S; Augelli-Szafran CE; Zhu J
    J Pharmacol Exp Ther; 2024 Sep; ():. PubMed ID: 39284625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice.
    Hammond HR; Eans SO; Cirino TJ; Ananthan S; Jimenez-Torres AC; Zhu J; McLaughlin JP
    NeuroImmune Pharm Ther; 2024 Mar; 3(1):1-6. PubMed ID: 38711842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter.
    Jiménez-Torres AC; Porter KD; Hastie JA; Adeniran C; Moukha-Chafiq O; Nguyen TH; Ananthan S; Augelli-Szafran CE; Zhan CG; Zhu J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum.
    Zhu J; Yuan Y; Midde NM; Gomez AM; Sun WL; Quizon PM; Zhan CG
    J Neurovirol; 2016 Jun; 22(3):282-92. PubMed ID: 26501780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.
    Sun WL; Quizon PM; Yuan Y; Zhang W; Ananthan S; Zhan CG; Zhu J
    Sci Rep; 2017 Jun; 7(1):3694. PubMed ID: 28623359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human dopamine transporter in NeuroAIDS.
    Zhu J; Ananthan S; Zhan CG
    Pharmacol Ther; 2018 Mar; 183():78-89. PubMed ID: 28987321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.
    Quizon PM; Yuan Y; Zhu Y; Zhou Y; Strauss MJ; Sun WL; Zhan CG; Zhu J
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):854-869. PubMed ID: 33537927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder.
    Ewens AN; Pilski A; Hastings SD; Krook-Magnuson C; Graves SM; Krook-Magnuson E; Thayer SA
    J Pharmacol Exp Ther; 2024 Sep; 391(1):104-118. PubMed ID: 39060163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of HIV-1 tat protein on methamphetamine-induced inhibition of vesicular monoamine transporter2-mediated dopamine transport and methamphetamine conditioned place preference in HIV-1 tat transgenic mice.
    Zhu J; Cirincione AB; Strauss MJ; Davis SE; Eans SO; Tribbitt DK; Alshakhshir N; McLaughlin JP
    Eur J Pharmacol; 2024 Dec; 984():177030. PubMed ID: 39366503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport.
    Sun WL; Quizon PM; Yuan Y; Strauss MJ; McCain R; Zhan CG; Zhu J
    Sci Rep; 2019 Mar; 9(1):3843. PubMed ID: 30846720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport.
    Quizon PM; Sun WL; Yuan Y; Midde NM; Zhan CG; Zhu J
    Sci Rep; 2016 Dec; 6():39048. PubMed ID: 27966610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iTat transgenic mice exhibit hyper-locomotion in the behavioral pattern monitor after chronic exposure to methamphetamine but are unaffected by Tat expression.
    Ayoub S; Kenton JA; Milienne-Petiot M; Deben DS; Achim C; Geyer MA; Perry W; Grant IE; Young JW; Minassian A;
    Pharmacol Biochem Behav; 2023 Jan; 222():173499. PubMed ID: 36462584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of HIV-1 TAT protein and methamphetamine exposure on visual discrimination and executive function in mice.
    Kesby JP; Fields JA; Chang A; Coban H; Achim CL; Semenova S;
    Behav Brain Res; 2018 Sep; 349():73-79. PubMed ID: 29709610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport.
    Midde NM; Yuan Y; Quizon PM; Sun WL; Huang X; Zhan CG; Zhu J
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):122-35. PubMed ID: 25604666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of KCC2 Membrane Localization in Striatal Dopamine D2 Receptor-Expressing Medium Spiny Neurons Rescues Locomotor Deficits in HIV Tat-Transgenic Mice.
    Barbour AJ; Nass SR; Hahn YK; Hauser KF; Knapp PE
    ASN Neuro; 2021; 13():17590914211022089. PubMed ID: 34445881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
    Midde NM; Gomez AM; Zhu J
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic methamphetamine exposure exerts few effects on the iTat mouse model of HIV, but blocks Tat expression-induced slowed reward retrieval.
    Young JW; Kenton JA; Milienne-Petiot M; Deben D; Achim C; Geyer MA; Perry W; Grant IE; Minassian A;
    Behav Brain Res; 2023 Feb; 437():114109. PubMed ID: 36108778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.